CT3N Symposium 2019

Center for Targeted Therapeutics and Translational Nanomedicine
CT3N Symposium 2019

Ilise Feitshans, JD, ScM, DIR, Fellow in International Law of Nanotechnology, European Scientific Institute, Archamps Technopole, University of Grenoble will speak about designing Compatibility: Polymer Nanomaterials for the Treatment of Soft Tissue Diseases

Please accept YouTube cookies to play this video. By accepting you will be accessing content from YouTube, a service provided by an external third party.

YouTube privacy policy

If you accept this notice, your choice will be saved and the page will refresh.

Wednesday, December 4, 2019
Perelman School of Medicine, University of Pennsylvania
Biomedical Research Building, Gaulton Auditorium and Lobby
421 Curie Boulevard, Philadelphia, PA 19104

Wednesday December 4, 2019
8:15- 8:45 a.m. Registration and Breakfast Gaulton Lobby
8:45- 9:00 a.m. Welcome & Introduction

Andrew Tsourkas, PhD, CT3N Co-Director, Co-Director, Chemical
and Nanoparticle Synthesis Core, Professor of Bioengineering
and Radiology, School of Engineering and Applied Science,
University of Pennsylvania

Gaulton Auditorium

Session I Keynote Lecture

Session Chair: Vladimir Muzykantov, MD, PhD, Co-Director, CT3N,
Professor of Pharmacology and Medicine, Vice-Chair of Faculty
Development, Department of Pharmacology, Perelman School of
Medicine, University of Pennsylvania

9:00- 9:50 a.m. Discovery and Translation of the Cell Membrane Coating

Liangfang Zhang, PhD, Professor of Nanoengineering,
Bioengineering, and Chemical Engineering, University of
California San Diego
Center for Targeted Therapeutics and
Translational Nanomedicine
CT3N Symposium 2019

Session II Cell-Derived Drug Delivery Technologies

Session Chair: Kara L. Spiller, PhD, Associate Professor, School of
Biomedical Engineering, Science, and Health Systems, Drexel

9:50- 10:25 a.m. Trojan Horses of the 21st Century: Targeted Delivery of

Therapeutics in Macrophages to the Brain
Elena Batrakova, PhD, Associate Professor, Center for
Nanotechnology in Drug Delivery Division of
Pharmacoengineering & Molecular Pharmaceutics, University of
North Carolina at Chapel Hill

10:25- 11:00 a.m. Extracellular Vesicles for Therapeutic and Diagnostic Use
Joy Wolfram, PhD, Assistant Professor of Medicine, Mayo Clinic

11:00 – 11:15 a.m. Coffee Break Gaulton Lobby

Session III Biomaterials and Nanocarriers

Session Chair: Michael Chorny, PhD, Associate Director of CT3N,
Research Associate Professor of Pediatrics, Children’s Hospital of

Gaulton Auditorium

11:15- 11:50 a.m. Nanotechnology Law for Commercialization of Nano-Enabled

Ilise Feitshans, JD, ScM, DIR, Fellow in International Law of
Nanotechnology, European Scientific Institute, Archamps
Technopole, University of Grenoble

11:50- 12:25 p.m. Designing Compatibility: Polymer Nanomaterials for the Treatment of Soft Tissue Diseases

Thomas Dziubla, PhD, Professor and Chair, Department of
Chemical and Materials Engineering, University of Kentucky
12:25- 1:00 p.m. Nanoparticle Design for Targeting to Caveolae and Neutrophils
Jacob Myerson, PhD, Research Associate, Department of
Pharmacology, University of Pennsylvania

1:00- 2:15 p.m. Lunch, Poster Viewing, and Networking Gaulton Lobby

Session IV Antibody Therapeutics and Engineering

Session Chair: Hans E. Huber, PhD, Associate Director of CT3N,
Adjunct Professor of Pharmacology, Perelman School of
Medicine, University of Pennsylvania

Gaulton Auditorium

2:15- 2:50 p.m. Drug-like Antibodies by Design and Directed Evolution
Peter M. Tessier, PhD, Albert M. Mattocks Professor,
Departments of Pharmaceutical Sciences, Chemical Engineering
and Biomedical Engineering, Biointerfaces Institute, University
of Michigan

2:50- 3:25 p.m. The Use of Virus-like Particles to Isolate Highly Specific Claudin 6

Antibodies for Targeting Solid Tumors
Benjamin Doranz, PhD, MBA, President and CEO, Integral
Molecular, Philadelphia

3:25- 4:00 p.m.

4:00- 4:15 p.m.

Targeting Tumor Metastasis with Engineered Multispecific
Jamie Spangler, PhD, Assistant Professor, Biomedical and
Chemical & Biomolecular Engineering, Johns Hopkins University
Coffee Break Gaulton Lobby

Session V Keynote Lecture

Session Chair: Andrew Tsourkas, PhD

Gaulton Auditorium

4:15- 5:05 p.m. Using Fluorescence Microscopy to Inform the Design of

Antibody-Based Therapeutics
Sally Ward, PhD, Professor, Department of Microbial
Pathogenesis & Immunology, University of Southampton (UK)
and Texas A&M University Health Science Center

5:05- 5:10 p.m. Closing Remarks

Vladimir Muzykantov, MD, PhD

5:10 – 6:10 p.m. Reception Gaulton Lobby

Leave a comment

Your email address will not be published.